Immunocore Holdings (Immunocore Holdings) Sale Of Investment : $0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Sale Of Investment?

Immunocore Holdings's sale of investment for the three months ended in Mar. 2024 was $0.0 Mil. It means Immunocore Holdings gained $0.0 Mil from selling investments. Immunocore Holdings's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was $0.0 Mil.

Compared with last quarter ($0.0 Mil in Dec. 2023 ), Immunocore Holdings gained the same money from selling investments in Mar. 2024 ($0.0 Mil).

Immunocore Holdings Sale Of Investment Historical Data

The historical data trend for Immunocore Holdings's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Sale Of Investment Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Investment

Get a 7-Day Free Trial

Immunocore Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Sale Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Immunocore Holdings Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Immunocore Holdings Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.